MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
9.4 M |
Market Cap[1] |
$ 528 M |
EBITDA (LTM) |
$ -108 M |
P/E (LTM) |
- |
P/S (LTM) |
82.638611 |
EPS (LTM) |
-9.06 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Coherus BioSciences
CHRS
|
$ 0.75 | -11.77 % | $ 87.9 M | Nasdaq Global Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 27.01 | -20.69 % | $ 3.44 B | Nasdaq Global Select Market,SPB | USA |
 |
Cellectis S.A.
CLLS
|
$ 1.01 | -13.68 % | $ 101 M | Nasdaq Global Market |  France |
 |
BeyondSpring
BYSI
|
$ 0.65 | -4.9 % | $ 26.7 M | Nasdaq Capital Market | USA |
 |
Alkermes plc
ALKS
|
$ 44.51 | -3.01 % | $ 7.33 B | Nasdaq Global Select Market |  Irlanda |
 |
Altimmune
ALT
|
$ 1.97 | -7.31 % | $ 174 M | Nasdaq Global Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 0.76 | -13.05 % | $ 50.8 M | Nasdaq Capital Market | USA |
 |
Citius Pharmaceuticals
CTXR
|
$ 0.55 | -0.07 % | $ 6.09 M | Nasdaq Capital Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 9.34 | -14.08 % | $ 256 M | Nasdaq Global Market,SPB |  Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 57.46 | -6.8 % | $ 7.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 8.04 | -3.94 % | $ 101 M | Nasdaq Global Select Market,SPB | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 16.17 | -5.49 % | $ 2.17 B | Nasdaq Global Market |  Canada |
 |
Cullinan Management
CGEM
|
$ 11.08 | -11.27 % | $ 668 M | Nasdaq Global Select Market | USA |
 |
BioNTech SE
BNTX
|
$ 85.83 | -5.37 % | $ 20.7 B | Nasdaq Global Select Market |  Germany |
 |
Replimune Group
REPL
|
$ 20.15 | -2.61 % | $ 1.87 B | Nasdaq Global Select Market | USA |
 |
Collegium Pharmaceutical
COLL
|
$ 25.17 | 6.34 % | $ 797 M | Nasdaq Global Select Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 2.84 | -20.45 % | $ 37.8 M | Nasdaq Global Market | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 1.27 | -8.63 % | $ 58 M | Nasdaq Capital Market | Israel |
 |
AnaptysBio
ANAB
|
$ 45.61 | -4.0 % | $ 1.32 B | Nasdaq Global Select Market,SPB | USA |
 |
Assembly Biosciences
ASMB
|
$ 19.94 | 0.35 % | $ 224 M | Nasdaq Global Select Market,SPB | USA |
 |
Adagene
ADAG
|
$ 2.02 | -16.18 % | $ 119 M | Nasdaq Global Market |  China |
 |
Benitec Biopharma
BNTC
|
$ 8.67 | -6.57 % | $ 404 M | Nasdaq Capital Market | USA |
 |
Denali Therapeutics
DNLI
|
$ 19.67 | -6.15 % | $ 3.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Amarin Corporation plc
AMRN
|
$ 11.56 | -5.63 % | $ 4.8 B | Nasdaq Global Market | Irlanda |
 |
Editas Medicine
EDIT
|
$ 2.53 | -6.99 % | $ 225 M | Nasdaq Global Select Market,SPB | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 28.28 | -9.88 % | $ 1.64 B | Nasdaq Global Select Market,SPB | USA |
 |
Cue Biopharma
CUE
|
$ 18.09 | -8.82 % | $ 1.71 B | Nasdaq Capital Market,SPB | USA |
 |
Equillium
EQ
|
$ 1.32 | -5.71 % | $ 75.6 M | Nasdaq Global Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.68 | -11.84 % | $ 95.5 M | Nasdaq Global Select Market,SPB | USA |
 |
Abeona Therapeutics
ABEO
|
$ 3.91 | -7.35 % | $ 207 M | Nasdaq Capital Market | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 21.23 | -1.12 % | $ 3.57 B | Nasdaq Global Select Market,SPB | USA |
 |
Atossa Therapeutics
ATOS
|
$ 2.04 | -3.77 % | $ 17.6 M | Nasdaq Capital Market | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
ADC Therapeutics SA
ADCT
|
$ 1.64 | -3.49 % | $ 208 M | NYSE |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
$ 32.46 | -5.7 % | $ 1.87 B | Nasdaq Global Select Market | USA |
 |
Ardelyx
ARDX
|
$ 2.98 | -9.57 % | $ 718 M | Nasdaq Global Market | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.43 | -38.22 % | $ 111 M | Nasdaq Global Market | USA |
 |
Alector
ALEC
|
$ 2.08 | -8.99 % | $ 214 M | Nasdaq Global Select Market,SPB | USA |
 |
ALX Oncology Holdings
ALXO
|
$ 1.14 | -16.54 % | $ 61.2 M | Nasdaq Global Select Market,SPB | USA |
 |
Amneal Pharmaceuticals
AMRX
|
$ 19.49 | -2.33 % | $ 6.11 B | NYSE | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 3.65 | -10.1 % | $ 699 M | Nasdaq Global Select Market | Canada |
 |
Agenus
AGEN
|
$ 6.42 | -7.89 % | $ 191 M | Nasdaq Capital Market | USA |
 |
AbCellera Biologics
ABCL
|
$ 11.11 | -9.52 % | $ 3.32 B | Nasdaq Global Select Market | Canada |
 |
Artelo Biosciences
ARTL
|
$ 2.12 | -8.77 % | $ 401 K | Nasdaq Global Select Market | USA |
|
Immatics N.V.
IMTX
|
$ 6.2 | -10.35 % | $ 759 M | Nasdaq Global Select Market | Germany |
 |
Aptevo Therapeutics
APVO
|
$ 1.24 | -9.49 % | $ 391 K | Nasdaq Capital Market | USA |
 |
Aligos Therapeutics
ALGS
|
$ 4.58 | -8.76 % | $ 45.3 M | Nasdaq Global Select Market | USA |
 |
Aclaris Therapeutics
ACRS
|
$ 3.62 | -1.63 % | $ 444 M | Nasdaq Global Select Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 26.8 | 0.32 % | $ 4.07 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.